RE:RE:RE:RE:RE:RE:Mr. Market is wrong on this?A pre clinical study would be an additional cost. As mentioned lots of studies have indicated the benefits of BG on reducing LDL and even Health Canada and a few other equivalents in other countries have said the same.
I've mentioned this before, any claims on health benefits of a BG pill will be backed by a reputable study and this will be the differentiator when it comes to marketing.
Minty_33 wrote: A pretty-clinical study and efficacy evaluation would potentially reduce the costs associated with a full blown study with the MHI if results fell short of expectations. So perhaps they know that the BG pill holds some weight when it come to reducing Cholesterol. How are we to know? Inept IR department and president that doesn't know how to communicate to shareholders and analysts.